Upgrade to SI Premium - Free Trial

IceCure Medical Ltd (ICCM)

1.08 +0.03 (2.86%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/25/26)

Latest Headlines

IceCure enrolls first patients in breast cancer cryoablation study October 20, 2026 7:56 AM - StreetInsider IceCure Enrolls First Patients in Its FDA-Approved Study for ProSense® Breast Cancer Cryoablation at Two U.S. Sites October 20, 2026 7:55 AM - PR NewsWire Form 6-K IceCure Medical Ltd. For: Oct 13 October 13, 2026 8:46 AM - SEC Filing IceCure Medical presents breast cryoablation data at EUSOBI meeting October 13, 2026 8:05 AM - StreetInsider IceCure Highlights Clinical Data and Strong Physician Engagement for ProSense® Breast Cancer Cryoablation at EUSOBI 2026 October 13, 2026 8:05 AM - PR NewsWire IceCure adds Legacy Health in Portland to breast cancer cryoablation study October 6, 2026 8:25 AM - StreetInsider IceCure Expands ProSense® ChoICE Study for Low-Risk Breast Cancer adding Legacy Health in Portland, OR as U.S. Clinical Site October 6, 2026 8:25 AM - PR NewsWire Form 6-K IceCure Medical Ltd. For: Oct 05 October 5, 2026 4:16 PM - SEC Filing Form 6-K IceCure Medical Ltd. For: Oct 05 October 5, 2026 6:30 AM - SEC Filing Form 6-K IceCure Medical Ltd. For: Sep 28 September 28, 2026 4:06 PM - SEC Filing Form 6-K IceCure Medical Ltd. For: Sep 10 September 10, 2026 8:51 AM - SEC Filing IceCure Medical wins China approval for its ProSense cryoablation system September 10, 2026 7:59 AM - StreetInsider IceCure Medical Receives Regulatory Approval to Market ProSense® in China September 10, 2026 7:59 AM - PR NewsWire Form 6-K IceCure Medical Ltd. For: Aug 24 August 24, 2026 8:15 AM - SEC Filing IceCure Medical signs Netherlands distribution deal with Scovas Medical August 24, 2026 7:50 AM - StreetInsider IceCure Signs Exclusive Distribution Agreement for ProSense® Cryoablation Systems in the Netherlands August 24, 2026 7:50 AM - PR NewsWire West Cancer Center cleared to enroll patients in IceCure breast study August 20, 2026 8:17 AM - StreetInsider West Cancer Center Receives IRB Approval to Commence IceCure's ChoICE Study for Breast Cancer Cryoablation August 20, 2026 8:16 AM - PR NewsWire Form EFFECT IceCure Medical Ltd. August 19, 2026 6:05 AM - SEC Filing Form EFFECT IceCure Medical Ltd. August 19, 2026 6:05 AM - SEC Filing Form 4 IceCure Medical Ltd. For: Aug 14 Filed by: Good Shad August 17, 2026 8:26 AM - SEC Filing Form 3 IceCure Medical Ltd. For: Aug 12 Filed by: Salton David August 17, 2026 8:18 AM - SEC Filing Form 4 IceCure Medical Ltd. For: Aug 14 Filed by: Tel-Tzure Tlalit Bussi August 17, 2026 8:17 AM - SEC Filing Form 4 IceCure Medical Ltd. For: Aug 14 Filed by: Levav Shay August 17, 2026 8:16 AM - SEC Filing Form 4 IceCure Medical Ltd. For: Aug 14 Filed by: Dotan Merav Nir August 17, 2026 8:16 AM - SEC Filing Form 4 IceCure Medical Ltd. For: Aug 14 Filed by: Peleg Meir August 17, 2026 8:16 AM - SEC Filing Form 4 IceCure Medical Ltd. For: Aug 12 Filed by: Chan Vincent Chun Hung August 17, 2026 8:15 AM - SEC Filing Form S-8 IceCure Medical Ltd. August 14, 2026 5:20 PM - SEC Filing Form 6-K IceCure Medical Ltd. For: Aug 14 August 14, 2026 4:17 PM - SEC Filing Form SCHEDULE 13G IceCure Medical Ltd. Filed by: ARMISTICE CAPITAL, LLC August 14, 2026 10:16 AM - SEC Filing Form POS AM IceCure Medical Ltd. August 13, 2026 4:41 PM - SEC Filing Form POS AM IceCure Medical Ltd. August 13, 2026 4:32 PM - SEC Filing Two peer-reviewed studies examine cryoablation's role in breast cancer care August 13, 2026 9:10 AM - StreetInsider IceCure Highlights Two New Peer-Reviewed Publications Supporting Cryoablation in Breast Cancer Treatment De-Escalation August 13, 2026 9:10 AM - PR NewsWire Form 6-K IceCure Medical Ltd. For: Jun 30 August 12, 2026 8:45 AM - SEC Filing IceCure Reports its Financial Results for the First Half of 2026 with 45% Revenue Growth Year-Over-Year August 12, 2026 8:30 AM - PR NewsWire Form 6-K IceCure Medical Ltd. For: Aug 11 August 11, 2026 4:16 PM - SEC Filing Form 6-K IceCure Medical Ltd. For: Aug 06 August 6, 2026 4:07 PM - SEC Filing IceCure Medical enrolls first patient site for breast cancer study August 6, 2026 8:05 AM - StreetInsider IceCure Medical Adds Adventist Health as U.S. Clinical Site for its Post-Marketing "ChoICE" Study for Low-Risk Breast Cancer Cryoablation Treatment August 6, 2026 8:05 AM - PR NewsWire IceCure Medical to Report First Half 2026 Financial and Operating Results on August 12, 2026 August 5, 2026 8:30 AM - PR NewsWire IceCure: SIO Petitions NCCN to Include Cryoablation in Breast Cancer Treatment Guidelines, Citing IceCure's FDA Clearance of ProSense® July 29, 2026 8:25 AM - PR NewsWire IceCure Medical Kicks Off its Post-Marketing "ChoICE" Study for the Low-Risk Breast Cancer Treatment at First U.S Clinical Site July 27, 2026 8:32 AM - PR NewsWire Full Article List